Skip to search.
 Dow Up 1.23% Nasdaq Up 1.01%

Biogen Idec Inc. (BIIB)

-NasdaqGS

146.10 Up 2.65(1.85%) 11:07AM EDT - Nasdaq Real Time Price

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2012Dec 30, 2011Sep 29, 2011Jun 29, 2011
Total Revenue 1,292,014   1,326,710   1,309,934   1,208,648  
Cost of Revenue133,197  139,637  123,527  100,503  
Gross Profit 1,158,817   1,187,073   1,186,407   1,108,145  
Operating Expenses
Research Development355,962  338,934  301,391  285,644  
Selling General and Administrative387,241  387,533  345,373  356,553  
Non Recurring283  636  1,803   -  
Others45,961  50,867  49,347  55,136  
Total Operating Expenses789,447  777,970  697,914   -  
Operating Income or Loss 369,370   409,103   488,493   410,812  
Income from Continuing Operations
Total Other Income/Expenses Net15,144  (3,973)(7,727)(11,728)
Earnings Before Interest And Taxes384,514  405,130  480,766  399,084  
Interest Expense -   -   -   -  
Income Before Tax384,514  405,130  480,766  399,084  
Income Tax Expense82,148  104,920  127,104  95,036  
Minority Interest295  28  (1,836)(16,015)
Net Income From Continuing Ops302,661  300,238  351,826  288,033  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 302,661   300,238   351,826   288,033  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 302,661   300,238   351,826   288,033  

Currency in USD.